Fund Holdings — SILVERARC CAPITAL MANAGEMENT, LLC

Total Portfolio Value:
$443.75M
Total Bought:
$116.39M
Total Sold:
$73.16M
Net Transaction:
+$43.22M
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Nuvalent Inc465,710371,441-94,269$35.33M$38.00M8.56%+$2.67M
Merus N V623,628635,439+11,811$36.90M$31.75M7.15%-$5.15M
Insmed Incorporated(INSM)140,000347,695+207,695$9.38M$25.38M5.72%+$16.00M
Avidity Biosciences Inc517,734475,555-42,179$21.15M$21.84M4.92%+$692.8K
Erasca, Inc.(ERAS)7,816,9266,946,488-870,438$18.45M$18.96M4.27%+$516.0K
Akero Therapeutics Inc625,087639,840+14,753$14.66M$18.36M4.14%+$3.69M
Veracyte, Inc.(VCYT)282,248470,565+188,317$6.12M$16.02M3.61%+$9.90M
Rhythm Pharmaceuticals, Inc.(RYTM)184,662255,578+70,916$7.58M$13.39M3.02%+$5.81M
Cogent Biosciences, Inc.(COGT)1,206,2141,221,362+15,148$10.17M$13.19M2.97%+$3.02M
Intra-Cellular Therapies Inc192,345167,110-25,235$13.17M$12.23M2.76%-$946.3K
Centessa Pharmaceuticals PlcADS0744,592+744,592$0$11.91M2.68%+$11.91M
UroGen Pharma Ltd.(URGN)1,102,000901,129-200,871$18.49M$11.44M2.58%-$7.05M
ORIC Pharmaceuticals, Inc.(ORIC)1,075,8121,099,490+23,678$7.61M$11.27M2.54%+$3.66M
Poseida Therapeutics Inc3,607,9993,687,548+79,549$10.54M$10.55M2.38%+$11.0K
Verona Pharma PlcADS304,633348,866+44,233$4.40M$10.04M2.26%+$5.63M
Alnylam Pharmaceuticals, Inc.(ALNY)36,00035,774-226$8.75M$9.84M2.22%+$1.09M
Geron Corporation(GERN)999,2701,801,561+802,291$4.24M$8.18M1.84%+$3.94M
Syndax Pharmaceuticals, Inc.(SNDX)370,000378,746+8,746$7.60M$7.29M1.64%-$305.2K
Vaxcyte, Inc.(PCVX)2,50060,500+58,000$188.8K$6.91M1.56%+$6.72M
Kalvista Pharmaceuticals Inc560,883574,558+13,675$6.61M$6.65M1.50%+$46.2K
Protagonist Therapeutics Inc0146,657+146,657$0$6.60M1.49%+$6.60M
C4 Therapeutics, Inc.(CCCC)1,442,8411,147,891-294,950$6.67M$6.54M1.47%-$122.9K
Sarepta Therapeutics, Inc.(SRPT)42,00051,245+9,245$6.64M$6.40M1.44%-$236.0K
Biodesix, Inc.(BDSX)1,808,9593,561,094+1,752,135$2.77M$6.34M1.43%+$3.57M
Elutia Inc.CL A(ELUT)1,603,5801,645,808+42,228$7.95M$6.27M1.41%-$1.68M
ADC Therapeutics SASHS(ADCT)1,768,7701,795,080+26,310$5.59M$5.65M1.27%+$65.2K
Gossamer Bio, Inc.(GOSS)5,500,0005,645,352+145,352$4.95M$5.57M1.25%+$613.6K
Olema Pharmaceuticals, Inc.(OLMA)546,863455,082-91,781$5.92M$5.43M1.22%-$483.4K
Helix Acquisition Corp IiCL A500,000513,369+13,369$5.11M$5.36M1.21%+$254.7K
ABIVAX Société AnonymeADS(ABVX)455,800461,660+5,860$6.03M$5.32M1.20%-$707.4K
Wave Life Sciences, Inc.SHS(WVE)495,471627,552+132,081$2.47M$5.15M1.16%+$2.67M
Disc Medicine, Inc.(IRON)101,187103,862+2,675$4.56M$5.10M1.15%+$543.3K
Biohaven Ltd.(BHVN)100,00099,566-434$3.47M$4.98M1.12%+$1.50M
Celldex Therapeutics, Inc.(CLDX)374,910145,000-229,910$13.88M$4.93M1.11%-$8.95M
Longboard Pharmaceuticals In122,849124,353+1,504$3.32M$4.14M0.93%+$824.1K
Biogen Inc.(BIIB)19,36519,940+575$4.49M$3.87M0.87%-$624.0K
Praxis Precision Medicines, Inc.(PRAX)67,29667,045-251$2.78M$3.86M0.87%+$1.07M
Modular Med Inc900,0001,440,000+540,000$1.42M$3.24M0.73%+$1.82M
Solid Biosciences Inc472,995457,739-15,256$2.68M$3.19M0.72%+$508.6K
BioNTech SEADS(BNTX)026,083+26,083$0$3.10M0.70%+$3.10M
Structure Therapeutics IncADS70,51670,5160$2.77M$3.09M0.70%+$325.8K
Mersana Therapeutics Inc2,500,5851,585,786-914,799$5.03M$3.00M0.68%-$2.03M
Relay Therapeutics, Inc.(RLAY)0419,242+419,242$0$2.97M0.67%+$2.97M
TELA Bio, Inc.(TELA)1,000,0001,124,928+124,928$4.70M$2.85M0.64%-$1.85M
Compugen Ltd.(CGEN)1,501,1131,501,1130$2.52M$2.72M0.61%+$195.1K
Cerus Corporation(CERS)1,465,7441,495,329+29,585$2.58M$2.60M0.59%+$22.2K
Zevra Therapeutics, Inc.(ZVRA)0350,000+350,000$0$2.43M0.55%+$2.43M
Perspective Therapeutics, Inc.(CATX)260,009167,986-92,023$2.59M$2.24M0.51%-$349.7K
BioAge Labs, Inc.(BIOA)0100,000+100,000$0$2.08M0.47%+$2.08M
Unicycive Therapeutics Inc04,000,000+4,000,000$0$1.63M0.37%+$1.63M
Trevi Therapeutics, Inc.(TRVI)844,235482,575-361,660$2.52M$1.61M0.36%-$904.0K
Xencor, Inc.(XNCR)075,507+75,507$0$1.52M0.34%+$1.52M
Tarsus Pharmaceuticals, Inc.(TARS)40,00040,0000$1.09M$1.32M0.30%+$228.4K
Kodiak Sciences Inc.(KOD)1,062,062500,000-562,062$2.50M$1.30M0.29%-$1.19M
Evogene Ltd.SHS NEW(EVGN)0307,974+307,974$0$945.5K0.21%+$945.5K
Molecular Templates Inc623,838623,8380$717.4K$876.5K0.20%+$159.1K
Applied Therapeutics Inc0100,000+100,000$0$850.0K0.19%+$850.0K
Vaxart, Inc.(VXRT)01,000,000+1,000,000$0$849.0K0.19%+$849.0K
EyePoint, Inc.(EYPT)100,000100,0000$870.0K$799.0K0.18%-$71.0K
Ascendis Pharma A/SADR(ASND)05,000+5,000$0$746.5K0.17%+$746.5K
Instil Bio, Inc.(TIL)010,517+10,517$0$708.0K0.16%+$708.0K
89bio Inc92,29892,2980$739.3K$683.0K0.15%-$56.3K
Karyopharm Therapeutics Inc.(KPTI)558,466558,4660$484.5K$463.5K0.10%-$21.0K
Black Diamond Therapeutics I0100,000+100,000$0$435.0K0.10%+$435.0K
Fractyl Health, Inc.(GUTS)166,666166,6660$711.7K$421.7K0.10%-$290.0K
Aligos Therapeutics, Inc.(ALGS)026,219+26,219$0$227.1K0.05%+$227.1K
Yarrow Bioscience Inc(YARW)467,39776,784-390,613$920.8K$144.4K0.03%-$776.4K
Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT)104,828104,8280$6.4K$6.8K0.00%+$398
Aligos Therapeutics Inc655,5150-655,515$229.4K$0—-$229.4K
Corbus Pharmaceuticals Holdings, Inc.(CRBP)172,4920-172,492$7.81M$0—-$7.81M
Engene Holdings Inc
COM
263,8410-263,841$2.49M$0—-$2.49M
Evogene LtdSHS3,079,7390-3,079,739$2.00M$0—-$2.00M
Fulcrum Therapeutics, Inc.(FULC)398,4360-398,436$2.47M$0—-$2.47M
Jasper Therapeutics, Inc.(JSPR)109,8920-109,892$2.49M$0—-$2.49M
MacroGenics, Inc.(MGNX)370,0000-370,000$1.57M$0—-$1.57M
Mirum Pharmaceuticals, Inc.(MIRM)79,1940-79,194$2.71M$0—-$2.71M
Morphic Hldg Inc486,3060-486,306$16.57M$0—-$16.57M
Relmada Therapeutics, Inc.(RLMD)99,3790-99,379$298.1K$0—-$298.1K
Soleno Therapeutics Inc15,0000-15,000$612.0K$0—-$612.0K
Stoke Therapeutics, Inc.(STOK)141,5180-141,518$1.91M$0—-$1.91M
Zura Bio LimitedCL A(ZURA)328,5040-328,504$1.15M$0—-$1.15M
Page 1 of 1
SILVERARC CAPITAL MANAGEMENT, LLC — 13F Holdings — Q3 2024 | TickerTrail